Aradi, Z.; Bói, B.; Nagy, G.; Antal-Szalmás, P.; Mezei, K.; Horváth, I.F.; Szántó, A.
Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate? Int. J. Mol. Sci. 2025, 26, 4797.
https://doi.org/10.3390/ijms26104797
AMA Style
Aradi Z, Bói B, Nagy G, Antal-Szalmás P, Mezei K, Horváth IF, Szántó A.
Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate? International Journal of Molecular Sciences. 2025; 26(10):4797.
https://doi.org/10.3390/ijms26104797
Chicago/Turabian Style
Aradi, Zsófia, Bernadett Bói, Gábor Nagy, Péter Antal-Szalmás, Kincső Mezei, Ildikó Fanny Horváth, and Antónia Szántó.
2025. "Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?" International Journal of Molecular Sciences 26, no. 10: 4797.
https://doi.org/10.3390/ijms26104797
APA Style
Aradi, Z., Bói, B., Nagy, G., Antal-Szalmás, P., Mezei, K., Horváth, I. F., & Szántó, A.
(2025). Additive Value of Rheumatoid Factor Isotypes in Sjögren’s Syndrome Patients with Joint Complaints of Different Etiologies—Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate? International Journal of Molecular Sciences, 26(10), 4797.
https://doi.org/10.3390/ijms26104797
